Hyperliquid Strategies reports $317.9M net loss for H1 FY2026; HYPE holdings 17.6M

Hyperliquid Strategies Inc

2026-Q2 EPS reported -$15.50 revenue$500,000

Six-month net loss of $317.9M, driven by $262.4M unrealized loss on HYPE tokens and $35.6M IPR&D write-off.
Revenue from interest ($0.9M) and staking ($0.5M); total assets $616.7M with no debt and stockholders' equity $589.8M.
Treasury deployed $129.5M to acquire 5M HYPE tokens, raising total holdings to 17.6M; $125M deployable capital remains.
Repurchased 3M PURR shares for $10.5M, reducing diluted share count to 150.6M.
Completed NASDAQ listing Dec 2, 2025 via business combination with Sonnet BioTherapeutics.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.